Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil®
Mesoblast (ASX:MSB) enters Medicaid agreement with CMS for Ryoncil®, enabling treatment for children with SR-aGvHD.
Category: Healthcare
Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Avecho Biotechnology Limited (ASX:AVE) Receives US$3M Licensing Fee from Sandoz
Avecho Biotechnology Limited (ASX:AVE) receives a US$3M upfront licensing fee from Sandoz AG for its CBD treatment for insomnia in Australia.
Healius (ASX:HLS) Announces Pathology Strategy and $300M Dividend at Investor Day 2025
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
Prescient Therapeutics (ASX:PTX) Initiates Phase 2a PTX-100 Clinical Study
Prescient Therapeutics (ASX:PTX) initiates Phase 2a clinical study for PTX-100, marking a significant milestone in treating Cutaneous T-Cell Lymphoma.
LTR Pharma Limited (ASX:LTP) Advances Multi-Market Strategy with FDA Milestone and Roxus Launch
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
4DMedical Limited (ASX:4DX) Announces $6.5m Annual Cost Reduction Program
4DMedical Limited (ASX:4DX) announces $6.5m annual cost reductions, supporting ongoing growth and key milestones.
Clinuvel (ASX:CUV) Announces Positive Preliminary Stroke Study Results
CLINUVEL (ASX:CUV) reports positive preliminary results from its latest stroke treatment study, highlighting high patient improvement rates.
Orthocell Limited (ASX:OCC) Completes First Sales of Striate+ in DACH Region
Orthocell Limited (ASX:OCC) achieves first sales of its Striate+ product in the DACH region, marking a significant expansion in its European markets.
EBR Systems (ASX:EBR) Advances Leadless Pacemaker Technology with Successful Trials
EBR Systems (ASX:EBR) reports successful SOLVE-CRT trials and outlines a clear FDA approval pathway for its innovative leadless pacemaker system.